Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Lung Cancer Location: a Repository

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT00578084
First received: December 19, 2007
Last updated: October 7, 2013
Last verified: September 2013
  Purpose

The purpose of this repository is to prospectively examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location. The data collected in this repository may be used to influence our current standard of care and streamline indications for EUS.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lung Cancer Location: A Prospective Repository

Resource links provided by NLM:


Further study details as provided by Indiana University:

Primary Outcome Measures:
  • examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location [ Time Frame: ongoing-database ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: June 2006
Study Completion Date: September 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
surgery
those subjects who went to surgery to treat their lung cancer
no surgery
those subjects who did not go to surgery for their lung cancer
NSCLC
subjects with NSCLC
Small cell lung cancer
those with small cell lung cancer

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects with known or suspected lung cancer will be identified by referral to the thoracic surgeon or ultrasonographer at the Veterans Affairs Hospital or Indiana University Medical Center.

Criteria

Inclusion Criteria:

  • Subjects undergoing EUS evaluation of a mediastinal mass, or suspected/known lung cancer
  • Subjects with a prior history of lung cancer
  • Subjects referred to thoracic surgery for evaluation of a suspected/known lung cancer

Exclusion Criteria:

  • Altered mental status that would prohibit the giving and understanding of informed consent
  • Dementia
  • Psychiatric illness that would preclude adequate compliance with communication for this protocol
  • Prisoners
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00578084

Locations
United States, Indiana
Clarian/IUPUI: University Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Investigators
Principal Investigator: Julia LeBlanc, MD, MPH Indiana University
  More Information

No publications provided

Responsible Party: Indiana University
ClinicalTrials.gov Identifier: NCT00578084     History of Changes
Other Study ID Numbers: 0604-76, IRB # 0604-76
Study First Received: December 19, 2007
Last Updated: October 7, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Lung Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms

ClinicalTrials.gov processed this record on November 23, 2014